abstract |
According to the present invention, by contacting a cell with an agent capable of inhibiting the interaction between CD40L on the cell and CD40, the CD40 ligand (CD40L) of smooth muscle cells carrying CD40 on the cell surface in vivo and in vitro Activation is inhibited. In vivo inhibition of CD40 bearing smooth muscle cells is used for the treatment of smooth muscle cell dependent diseases. |